EX
EXPO.US Exponent Inc
- Market cap
- USD 4.15B
- P/E
- 37.2x
- P/B
- 13.32x
- ROE
- 38.9%
- Dividend yield
- 1.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is EXPO.US undervalued?
Graham numberThe Graham number of Exponent Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Exponent Inc fundamental analysis
No fundamental analysis for Exponent Inc yet.
Exponent Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Exponent Inc
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, material…
Full company profileExponent Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Exponent Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 315M | 348M | 380M | 417M | 400M | 466M | 513M | 537M | 559M | 582M | 682M |
| Gross Profit | 299M | 330M | 355M | 391M | 400M | 434M | 478M | 136M | 142M | 145M | 176M |
| Operating Income | 61.9M | 72.1M | 91.5M | 85.1M | 83.2M | 109M | 141M | 111M | 120M | 120M | 148M |
| EBITDA | 68.0M | 78.3M | 97.7M | 91.9M | 90.1M | 115M | 148M | 145M | 157M | 157M | 162M |
| Net Income | 47.5M | 41.3M | 72.3M | 82.5M | 82.6M | 101M | 102M | 100M | 109M | 106M | 120M |
| EPS | 0.87 | 0.77 | 1.33 | 1.53 | 1.55 | 1.90 | 1.96 | 1.94 | 2.11 | 2.07 | 2.48 |
| Balance Sheet | |||||||||||
| Total Assets | 404M | 440M | 469M | 563M | 594M | 684M | 587M | 647M | 777M | 778M | 693M |
| Total Liabilities | 130M | 151M | 155M | 213M | 232M | 267M | 266M | 291M | 356M | 387M | 385M |
| Shareholders' Equity | 273M | 289M | 314M | 350M | 361M | 417M | 321M | 356M | 421M | 390M | 308M |
| Cash & Short-term Investments | 174M | 196M | 209M | 232M | 243M | 298M | 161M | 187M | 259M | 222M | 115M |
| Total Debt | - | - | - | 24.1M | 20.3M | 15.0M | 18.6M | 28.3M | 81.5M | 82.8M | 81.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 66.9M | 67.8M | 91.2M | 108M | 103M | 125M | 93.8M | 127M | 145M | 132M | 124M |
| Capital Expenditure | 14.4M | 4.73M | 16.3M | 23.0M | 4.99M | 6.83M | 12.0M | 16.4M | 6.94M | 9.39M | 7.18M |
| Free Cash Flow | 52.6M | 63.1M | 74.9M | 85.0M | 98.3M | 118M | 81.8M | 111M | 138M | 122M | 117M |
| Ratios | |||||||||||
| ROE | 17.4% | 14.3% | 23.0% | 23.5% | 22.8% | 24.3% | 31.9% | 28.2% | 25.9% | 27.2% | 38.9% |
| ROA | 11.8% | 9.4% | 15.4% | 14.6% | 13.9% | 14.8% | 17.4% | 15.5% | 14.0% | 13.6% | 17.3% |
| Net Profit Margin | 15.1% | 11.9% | 19.0% | 19.8% | 20.6% | 21.7% | 19.9% | 18.7% | 19.5% | 18.2% | 17.6% |
| Debt to Equity | - | - | - | 0.07x | 0.06x | 0.04x | 0.06x | 0.08x | 0.19x | 0.21x | 0.26x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Exponent Inc dividends
- Dividend yield
- 1.48%
- Forward dividend
- 1.24 USD
- Payout ratio
- 58.1%
- Ex-dividend date
- Dec 4, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 61.5M | 1.20 | 58.1% |
| 2024 | USD 58.2M | 1.13 | 53.4% |
| 2023 | USD 54.0M | 1.05 | 53.9% |
| 2022 | USD 49.2M | 0.94 | 48.1% |
| 2021 | USD 43.2M | 0.81 | 42.7% |
| 2020 | USD 39.8M | 0.75 | 48.2% |
| 2019 | USD 33.5M | 0.62 | 40.6% |
| 2018 | USD 27.2M | 0.50 | 37.7% |
| 2017 | USD 21.8M | 0.40 | 52.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 8, 2018.
Who owns Exponent Inc
- Insiders 1.24%
- Institutions 98.76%
- Public & others 0.00%
- Shares outstanding 47.6M
- Free float 46.9M
Top funds holding EXPO.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 1.71M | 3.59% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.48M | 3.11% | -4.32% | Sep 2026 |
| iShares Russell 2000 ETF | 1.24M | 2.60% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 1.07M | 2.25% | -4.03% | Sep 2026 |
| First Trust SMID Cp Rising Div Achv ETF | 1.06M | 2.24% | 0.00% | Oct 2026 |
| Global X US Infrastructure Dev ETF | 752K | 1.58% | -0.03% | Oct 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 596K | 1.25% | -7.00% | Sep 2026 |
| Virtus KAR Mid-Cap Core I | 554K | 1.17% | -11.48% | Jun 2026 |
| Fidelity Small Cap Index | 540K | 1.14% | +0.11% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 462K | 0.97% | -0.38% | Oct 2026 |
| Invesco S&P MidCap Quality ETF | 461K | 0.97% | +0.15% | Oct 2026 |
| Virtus KAR Small-Mid Cap Core R6 | 457K | 0.96% | +20.82% | Jun 2026 |
| Royce Premier Invmt | 398K | 0.84% | 0.00% | Sep 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 352K | 0.74% | -0.91% | Sep 2026 |
| Column Mid Cap Select | 311K | 0.65% | +8.27% | Sep 2026 |
| CIBC US Small Companies | 293K | 0.62% | 0.00% | Jul 2026 |
| Vanguard Russell 2000 ETF | 287K | 0.60% | +1.16% | Sep 2026 |
| Nationwide Geneva Small Cap Gr Instl Svc | 284K | 0.60% | -4.89% | Oct 2026 |
| Conestoga Small Cap Investors | 277K | 0.58% | -14.93% | Sep 2026 |
| Vanguard Dividend Appreciation ETF | 269K | 0.57% | -2.03% | Sep 2026 |
Top institutions holding EXPO.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 6.18M | 13.01% | +1.91% | Jun 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 4.00M | 8.40% | +2.81% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 3.14M | 6.61% | +6.68% | Jun 2026 |
| Vanguard Capital Management, LLC | 2.18M | 4.59% | -1.38% | Jun 2026 |
| State Street Corp | 1.94M | 4.09% | +2.86% | Jun 2026 |
| Geode Capital Management, LLC | 1.75M | 3.68% | +6.09% | Jun 2026 |
| Geneva Capital Management | 1.41M | 2.96% | -21.74% | Jun 2026 |
| Royce & Associates, LP | 1.32M | 2.78% | +15.57% | Jun 2026 |
| Conestoga Capital Advisors, LLC | 1.27M | 2.66% | -33.61% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.21M | 2.55% | +13.25% | Jun 2026 |
| AQR Capital Management LLC | 1.14M | 2.41% | +16.67% | Jun 2026 |
| First Trust Advisors L.P. | 1.08M | 2.28% | +12.29% | Jun 2026 |
| Two Sigma Investments LLC | 1.03M | 2.17% | -6.16% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.03M | 2.17% | +10.98% | Sep 2026 |
| NORGES BANK | 884K | 1.86% | +19.99% | Jun 2026 |
| Resona Asset Management Co., Ltd. | 754K | 1.59% | +9.11% | Jun 2026 |
| Northern Trust Corp | 648K | 1.36% | -2.37% | Jun 2026 |
| Wells Fargo & Co | 568K | 1.19% | -7.34% | Jun 2026 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 560K | 1.18% | +8.10% | Jun 2026 |
| Amvescap Plc. | 534K | 1.12% | -6.74% | Jun 2026 |
Exponent Inc company profile
- Company name
- Exponent Inc
- Ticker
- EXPO.US
- Exchange
- USA Stocks
- Listed since
- Aug 17, 1990
- Sector
- Industrials
- Industry
- Professional Services
- Employees
- 1,016
- Fiscal year end
- December
- Address
- 149 Commonwealth Drive, Menlo Park, CA, United States, 94025
- Phone
- 650 326 9400
- Website
- exponent.com
About Exponent Inc
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
Exponent Inc management
10- Dr. Catherine Ford Corrigan P.E., Ph.D.CEO & Director · born 1969
- Mr. Richard L. Schlenker Jr.Executive VP, Corporate Secretary & Director · born 1966
- Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D.Group Vice President · born 1969
- Dr. Joseph Rakow Ph.D.Group Vice President · born 1977
- Dr. Joseph Sala Ph.D.Group Vice President · born 1977
- Dr. John D. Pye P.E., Ph.D.President · born 1971
- Dr. Bernard Ross P.E., Ph.D.Co-Founder & Principal Engineer
- Mr. Eric R. AndersonChief Financial Officer · born 1975
- Ms. Gina FlynnVP of Legal & General Counsel
- Mr. Brian KundertChief Human Resources Officer · born 1975